Semaglutide (Wegovy) and tirzepatide (Mounjaro) are licensed in the UK and supported by NICE guidance for weight management and type 2 diabetes
(2025, July 29)
Supplies Needed For injecting GLP-1 medications from a vial, you'll need: A vial of the prescribed GLP-1 medication Sterile syringes (usually with a 1 mL capacity) Alcohol swabs A sharps disposal container Storage and Handling Keep the medication refrigerated between 36F and 46F (2C and 8C)
According to FDA labeling and American Diabetes Association guidelines, GLP-1 receptor agonists are indicated for type 2 diabetes (as an adjunct to diet and exercise) and for chronic weight management in adults with BMI 30 kg/m or 27 kg/m with at least one weight-related comorbidity
Understanding Retatrutide Raw Powder Stability Retatrutide Raw Powder, a triple-agonist peptide targeting GLP-1, GIP, and glucagon receptors, represents a significant advancement in metabolic therapeutic compounds
Published mid-stage research has reported weight and metabolic changes in selected study groups, but those findings do not make retatrutide a routine treatment
